Healthcare provider profile · identity verified

Hardik Patel, MD

Internal Medicine · THE VILLAGES, FL · NPI 1609430727

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	273	109
Methylprednisolone	Methylprednisolone	266	251
Amlodipine Besylate	Amlodipine Besylate	198	93
Levothyroxine Sodium	Levothyroxine Sodium	155	58
Losartan Potassium	Losartan Potassium	116	46
Lisinopril	Lisinopril	111	43
Pantoprazole Sodium	Pantoprazole Sodium	107	60
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	106	102
Furosemide	Furosemide	101	68
Metformin Hcl	Metformin Hcl	98	41
Tamsulosin Hcl	Tamsulosin Hcl	97	38
Rosuvastatin Calcium	Rosuvastatin Calcium	96	43
Metoprolol Succinate	Metoprolol Succinate	95	49
Eliquis	Apixaban	81	47
Metoprolol Tartrate	Metoprolol Tartrate	79	43
Cefdinir	Cefdinir	74	72
Levofloxacin	Levofloxacin	71	71
Tramadol Hcl	Tramadol Hcl	67	31
Azithromycin	Azithromycin	62	60
Meloxicam	Meloxicam	62	51
Omeprazole	Omeprazole	61	25
Gabapentin	Gabapentin	58	29
Hydrochlorothiazide	Hydrochlorothiazide	57	22
Trazodone Hcl	Trazodone Hcl	56	26
Doxycycline Hyclate	Doxycycline Hyclate	55	54
Carvedilol	Carvedilol	54	31
Clopidogrel	Clopidogrel Bisulfate	51	29
Simvastatin	Simvastatin	46	21
Potassium Chloride	Potassium Chloride	45	41
Finasteride	Finasteride	44	16
Fluticasone Propionate	Fluticasone Propionate	39	35
Prednisone	Prednisone	38	24
Pravastatin Sodium	Pravastatin Sodium	37	13
Albuterol Sulfate Hfa	Albuterol Sulfate	35	24
Glimepiride	Glimepiride	35	12
Duloxetine Hcl	Duloxetine Hcl	34	15
Famotidine	Famotidine	32	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	12
Baclofen	Baclofen	30	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	29
Alprazolam	Alprazolam	28	15
Metformin Hcl Er	Metformin Hcl	28	13
Sertraline Hcl	Sertraline Hcl	28	13
Jardiance	Empagliflozin	25	suppressed
Ofloxacin	Ofloxacin	25	21
Alendronate Sodium	Alendronate Sodium	24	11
Montelukast Sodium	Montelukast Sodium	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	11
Mirtazapine	Mirtazapine	22	12
Oxybutynin Chloride	Oxybutynin Chloride	22	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	17
Zolpidem Tartrate	Zolpidem Tartrate	22	13
Ezetimibe	Ezetimibe	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	15
Amiodarone Hcl	Amiodarone Hcl	20	13
Atenolol	Atenolol	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	20
Tizanidine Hcl	Tizanidine Hcl	20	20
Ozempic	Semaglutide	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Metronidazole	Metronidazole	18	18
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Bumetanide	Bumetanide	14	11
Memantine Hcl	Memantine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	13
Nystatin	Nystatin	13	12
Ondansetron Hcl	Ondansetron Hcl	13	11
Repatha Sureclick	Evolocumab	13	suppressed
Cephalexin	Cephalexin	12	11
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	11
Xarelto	Rivaroxaban	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error